- Home
- Publications
- Publication Search
- Publication Details
Title
Regulatory cells and the effect of cancer immunotherapy
Authors
Keywords
-
Journal
Molecular Cancer
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-02-04
DOI
10.1186/s12943-023-01714-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity
- (2022) Kebria Hezaveh et al. IMMUNITY
- CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory
- (2022) Yujiro Kidani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models
- (2022) Xin Chen et al. Frontiers in Immunology
- Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer
- (2022) Shingo Maeda et al. Journal for ImmunoTherapy of Cancer
- Biomarkers of response to PD-1 pathway blockade
- (2022) Hanxiao Li et al. BRITISH JOURNAL OF CANCER
- Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers
- (2022) Hiroaki Wakiyama et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy
- (2022) Peter John et al. Nature Communications
- Nanodrugs Targeting T Cells in Tumor Therapy
- (2022) Maximilian Haist et al. Frontiers in Immunology
- Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer
- (2022) Alexey Revenko et al. Journal for ImmunoTherapy of Cancer
- Update in TIGIT Immune-Checkpoint Role in Cancer
- (2022) Tiziana Annese et al. Frontiers in Oncology
- GITR Antibodies in Cancer: Not Ready for Prime Time
- (2022) Tatiana Hernandez-Guerrero et al. CLINICAL CANCER RESEARCH
- T-cell immunoglobulin and ITIM domain in cancer immunotherapy: A focus on tumor-infiltrating regulatory T cells
- (2022) Xiaoyan Tian et al. MOLECULAR IMMUNOLOGY
- First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors
- (2022) Elizabeth J Davis et al. Journal for ImmunoTherapy of Cancer
- Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell antitumor immunity
- (2022) Anqi Li et al. Journal for ImmunoTherapy of Cancer
- Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
- (2021) Helena Van Damme et al. Journal for ImmunoTherapy of Cancer
- Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Escherichia coli Combined with Immunogenic Cell Death for Cancer Immunotherapy
- (2021) Baicheng Wei et al. NANO LETTERS
- Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high‐grade serous ovarian cancer
- (2021) Guodong Zhang et al. Cancer Medicine
- Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy
- (2021) Yu-Chen Wang et al. Nature Communications
- MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication Between Kupffer Cells and Regulatory T Cells
- (2021) Ningning Liu et al. GASTROENTEROLOGY
- Effector memory cytotoxic CD3+/CD8+/CD45RO+ T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer
- (2021) Xiangjie Sun et al. MODERN PATHOLOGY
- Targeting regulatory T cells in anti‐PD‐1/PD‐L1 cancer immunotherapy
- (2021) Galina Zhulai et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Targeting TREM2 on tumor-associated macrophages enhances immunotherapy
- (2021) Mikhail Binnewies et al. Cell Reports
- Relationship Between Progression‐Free Survival, Objective Response Rate, and Overall Survival in Clinical Trials of PD‐1/PD‐L1 Immune Checkpoint Blockade: A Meta‐Analysis
- (2020) Jiabu Ye et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Macrophage M1/M2 polarization
- (2020) Chen Yunna et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Immune Landscape in Tumor Microenvironment: Implications for Biomarker Development and Immunotherapy
- (2020) Karim Pérez-Romero et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
- (2020) Min-Hee Oh et al. JOURNAL OF CLINICAL INVESTIGATION
- Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
- (2020) Sai Ping Lau et al. Journal for ImmunoTherapy of Cancer
- Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer
- (2020) Jin Shang et al. Frontiers in Immunology
- Future of immune checkpoint inhibitors: focus on tumor immune microenvironment
- (2020) Yunlong Jia et al. Annals of Translational Medicine
- Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
- (2020) Weiqiang Lu et al. EMBO Molecular Medicine
- Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy
- (2020) Sundee Dees et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Macrophages in Organ Transplantation
- (2020) Farideh Ordikhani et al. Frontiers in Immunology
- Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin
- (2019) Young Suk Lee et al. Innate Immunity
- BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis
- (2019) Shipra Das et al. ONCOGENE
- First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
- (2019) Branimir I. Sikic et al. JOURNAL OF CLINICAL ONCOLOGY
- Cell–cell contact with proinflammatory macrophages enhances the immunotherapeutic effect of mesenchymal stem cells in two abortion models
- (2019) Yanhong Li et al. Cellular & Molecular Immunology
- Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
- (2019) Man Liu et al. GUT
- Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
- (2019) Melvyn T. Chow et al. IMMUNITY
- AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging
- (2019) Antero Salminen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
- (2019) Stefanie K. Wculek et al. Journal for ImmunoTherapy of Cancer
- Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets
- (2019) Chiara Napoletano et al. Journal of Clinical Medicine
- Targeting Treg cells in cancer immunotherapy
- (2019) Atsushi Tanaka et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- TMEM203 is a binding partner and regulator of STING-mediated inflammatory signaling in macrophages
- (2019) Yang Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The effects of monoclonal anti‐CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia
- (2019) C.K. Brierley et al. TRANSFUSION
- Therapeutic strategies for the costimulatory molecule OX40 in T-cell mediated immunity
- (2019) Yu Fu et al. Acta Pharmaceutica Sinica B
- Cancer Stem Cells and Targeting Strategies
- (2019) Luisa Barbato et al. Cells
- The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
- (2019) Gregg B. Fields Cells
- Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor
- (2019) Bao-Hua Li et al. MOLECULAR IMMUNOLOGY
- Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
- (2019) Anfray et al. Cells
- Regulatory T cells: a potential target in cancer immunotherapy
- (2018) Kohei Shitara et al. Annals of the New York Academy of Sciences
- Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras
- (2018) Isabelle Dierckx de Casterlé et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The role of STAT3 in leading the crosstalk between human cancers and the immune system
- (2018) Yu Wang et al. CANCER LETTERS
- Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma
- (2018) Remi Adelaiye-Ogala et al. CANCER RESEARCH
- Liposomal CpG-ODN: An in vitro and in vivo study on macrophage subtypes responses, biodistribution and subsequent therapeutic efficacy in mice models of cancers
- (2018) Sara Nikoofal-Sahlabadi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Myeloid-derived suppressor cell: Roles in the tumor microenvironment and tumor radiotherapy
- (2018) Zhongnan Yin et al. INTERNATIONAL JOURNAL OF CANCER
- Macrophage plasticity, polarization, and function in health and disease
- (2018) Abbas Shapouri-Moghaddam et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Distal airway microbiome is associated with immunoregulatory myeloid cell responses in lung transplant recipients
- (2018) Nirmal S. Sharma et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
- (2018) Viktor Fleming et al. Frontiers in Immunology
- Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
- (2018) Richard P. Tobin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
- (2018) Antoni Ribas et al. Cancer Discovery
- Anti-glucocorticoid-induced Tumor Necrosis Factor–Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects
- (2018) Jonathan E. Schoenhals et al. Frontiers in Immunology
- Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
- (2018) Veronica Huber et al. JOURNAL OF CLINICAL INVESTIGATION
- Hyperprogressive disease: recognizing a novel pattern to improve patient management
- (2018) Stéphane Champiat et al. Nature Reviews Clinical Oncology
- WDFY4 is required for cross-presentation in response to viral and tumor antigens
- (2018) Derek J. Theisen et al. SCIENCE
- Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity
- (2017) Andrés Alloatti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cells
- (2017) Yushe Dang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Macrophages as Key Drivers of Cancer Progression and Metastasis
- (2017) Sebastian R. Nielsen et al. MEDIATORS OF INFLAMMATION
- Effective combinatorial immunotherapy for castration-resistant prostate cancer
- (2017) Xin Lu et al. NATURE
- cGAS is essential for the antitumor effect of immune checkpoint blockade
- (2017) Hua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DHRS9 Is a Stable Marker of Human Regulatory Macrophages
- (2017) Paloma Riquelme et al. TRANSPLANTATION
- Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models
- (2017) Melinda Mata et al. Cancer Discovery
- Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity
- (2017) Karla R. Wiehagen et al. Cancer Immunology Research
- Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
- (2017) Michael A. Cannarile et al. Journal for ImmunoTherapy of Cancer
- Inhibition of tumor growth and metastasis by photoimmunotherapy targeting tumor-associated macrophage in a sorafenib-resistant tumor model
- (2016) Chenran Zhang et al. BIOMATERIALS
- Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen
- (2016) Emeric Limagne et al. CANCER RESEARCH
- Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
- (2016) A. Martens et al. CLINICAL CANCER RESEARCH
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- The molecular mechanisms of TLR-signaling cooperation in cytokine regulation
- (2016) Qian Liu et al. IMMUNOLOGY AND CELL BIOLOGY
- Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer
- (2016) Emma Eriksson et al. Journal of Translational Medicine
- Macrophage Susceptibility to Emactuzumab (RG7155) Treatment
- (2016) Leon P. Pradel et al. MOLECULAR CANCER THERAPEUTICS
- Local convection-enhanced delivery of an anti-CD40 agonistic monoclonal antibody induces antitumor effects in mouse glioma models
- (2016) Takuhiro Shoji et al. NEURO-ONCOLOGY
- Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
- (2016) Heleen H. Van Acker et al. PHARMACOLOGY & THERAPEUTICS
- The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
- (2016) D. F. Quail et al. SCIENCE
- Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
- (2016) Jeffrey J. Wallin et al. Nature Communications
- Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
- (2016) Anna-Maria Georgoudaki et al. Cell Reports
- M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment
- (2015) E. Van Overmeire et al. CANCER RESEARCH
- Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
- (2015) Tamás Rőszer MEDIATORS OF INFLAMMATION
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
- (2015) Emanuela Romano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment
- (2015) Qian-Qian Zhang et al. Scientific Reports
- Bottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells
- (2015) Natalia Escacena et al. Stem Cells International
- Recent Aspects of Sunitinib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma: a Systematic Review of the Literature
- (2015) Daniele Minardi et al. Current Urology Reports
- VISTA Regulates the Development of Protective Antitumor Immunity
- (2014) I. Le Mercier et al. CANCER RESEARCH
- OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy
- (2014) Yannick Bulliard et al. IMMUNOLOGY AND CELL BIOLOGY
- Cellular Metabolism and Macrophage Functional Polarization
- (2014) Linnan Zhu et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Dimethyl Sulfoxide Suppresses Mouse 4T1 Breast Cancer Growth by Modulating Tumor-Associated Macrophage Differentiation
- (2014) Rui Deng et al. Journal of Breast Cancer
- Regulatory T Cells and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment Undergo Fas-Dependent Cell Death during IL-2/ CD40 Therapy
- (2014) J. M. Weiss et al. JOURNAL OF IMMUNOLOGY
- Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
- (2014) Francois Moisan et al. Molecular Oncology
- Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
- (2014) Khaled Ali et al. NATURE
- Setback for JAK2 inhibitors
- (2014) Mark Ratner NATURE BIOTECHNOLOGY
- Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
- (2014) Hong Qin et al. NATURE MEDICINE
- Is there new hope for therapeutic matrix metalloproteinase inhibition?
- (2014) Roosmarijn E. Vandenbroucke et al. NATURE REVIEWS DRUG DISCOVERY
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Tumor Angiogenesis by Interferon-γ by Suppression of Tumor-Associated Macrophage Differentiation
- (2014) Tao Sun et al. ONCOLOGY RESEARCH
- Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
- (2013) Andrea Casazza et al. CANCER CELL
- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
- (2013) D. Sugiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
- (2013) M. J. Selby et al. Cancer Immunology Research
- Trabectedin
- (2013) Paola Allavena et al. OncoImmunology
- Thymosin α1 and cancer: action on immune effector and tumor target cells
- (2012) Enrico Garaci et al. Annals of the New York Academy of Sciences
- Aptamer-Mediated Blockade of IL4R Triggers Apoptosis of MDSCs and Limits Tumor Progression
- (2012) F. Roth et al. CANCER RESEARCH
- CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
- (2012) A. J. Rech et al. Science Translational Medicine
- Mesenchymal stem cells engineered for cancer therapy
- (2011) Khalid Shah ADVANCED DRUG DELIVERY REVIEWS
- Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
- (2011) P. Allavena et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy
- (2011) Zhen Huang et al. JOURNAL OF CONTROLLED RELEASE
- High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma
- (2010) Sandra Rauser et al. BMC CANCER
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells
- (2010) Sameena Khan et al. CLINICAL IMMUNOLOGY
- Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression
- (2010) Guangwen Ren et al. JOURNAL OF IMMUNOLOGY
- The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity
- (2010) Matthew A Bill et al. Molecular Cancer
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β
- (2009) Taku Nagai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation
- (2007) Karen English et al. IMMUNOLOGY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search